1. Home
  2. DHX vs HURA Comparison

DHX vs HURA Comparison

Compare DHX & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DHX
  • HURA
  • Stock Information
  • Founded
  • DHX 1991
  • HURA 2009
  • Country
  • DHX United States
  • HURA United States
  • Employees
  • DHX N/A
  • HURA N/A
  • Industry
  • DHX Business Services
  • HURA
  • Sector
  • DHX Consumer Discretionary
  • HURA
  • Exchange
  • DHX Nasdaq
  • HURA Nasdaq
  • Market Cap
  • DHX 143.1M
  • HURA 126.1M
  • IPO Year
  • DHX 2007
  • HURA N/A
  • Fundamental
  • Price
  • DHX $2.93
  • HURA $2.50
  • Analyst Decision
  • DHX Strong Buy
  • HURA Strong Buy
  • Analyst Count
  • DHX 2
  • HURA 2
  • Target Price
  • DHX $5.25
  • HURA $11.50
  • AVG Volume (30 Days)
  • DHX 223.7K
  • HURA 278.8K
  • Earning Date
  • DHX 11-11-2025
  • HURA 11-13-2025
  • Dividend Yield
  • DHX N/A
  • HURA N/A
  • EPS Growth
  • DHX N/A
  • HURA N/A
  • EPS
  • DHX N/A
  • HURA N/A
  • Revenue
  • DHX $134,396,000.00
  • HURA N/A
  • Revenue This Year
  • DHX N/A
  • HURA N/A
  • Revenue Next Year
  • DHX N/A
  • HURA N/A
  • P/E Ratio
  • DHX N/A
  • HURA N/A
  • Revenue Growth
  • DHX N/A
  • HURA N/A
  • 52 Week Low
  • DHX $1.21
  • HURA $1.80
  • 52 Week High
  • DHX $3.34
  • HURA $8.40
  • Technical
  • Relative Strength Index (RSI)
  • DHX 56.29
  • HURA 44.51
  • Support Level
  • DHX $2.68
  • HURA $2.28
  • Resistance Level
  • DHX $3.02
  • HURA $2.65
  • Average True Range (ATR)
  • DHX 0.21
  • HURA 0.17
  • MACD
  • DHX 0.02
  • HURA -0.04
  • Stochastic Oscillator
  • DHX 52.38
  • HURA 23.91

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: